The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $59.63

Today's change-0.07 -0.12%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $59.63

Today's change-0.07 -0.12%
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.07

Bristol-Myers Squibb Co closed lower Friday, dropping (U.S.)$0.07 or 0.12% to (U.S.)$59.63. Over the last five days, shares have lost 4.07% and are down 13.32% for the last year to date. This security has outperformed the S&P 500 by 7.85% during the last year.

Key company metrics

  • Open(U.S.) $59.75
  • Previous close(U.S.) $59.70
  • High(U.S.) $60.06
  • Low(U.S.) $58.99
  • Bid / Ask-- / --
  • YTD % change-13.32%
  • Volume7,129,501
  • Average volume (10-day)9,199,316
  • Average volume (1-month)7,584,723
  • Average volume (3-month)6,818,076
  • 52-week range(U.S.) $51.82 to (U.S.) $70.87
  • Beta0.54
  • Trailing P/E61.62×
  • P/E 1 year forward25.17×
  • Forward PEG1.21×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.55%
  • Trailing EPS(U.S.) $0.97
Updated February 5 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.08%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4,0694,1634,0414,258
Total other revenue--------
Total revenue4,0694,1634,0414,258
Gross profit2,9873,1753,2283,323
Total cost of revenue1,082988813935
Total operating expense3,2864,1182,7524,318
Selling / general / administrative1,1761,1351,0291,364
Research & development1,0239851,0161,139
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1801,14498927
Other operating expenses, total-175-134-204-47
Operating income783451,289-60
Interest income (expense), net non-operating-41-49-51-53
Gain (loss) on sale of assets2088154-3
Other--------
Income before tax987521,448-60
Income after tax730-1101,19927
Income tax, total257162249-87
Net income706-1301,18613
Total adjustments to net income--------
Net income before extra. items706-1301,18613
Minority interest-24-20-13-14
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items706-1301,18613
Inc. avail. to common incl. extra. items706-1301,18613
Diluted net income706-1301,18613
Dilution adjustment--------
Diluted weighted average shares1,6781,6671,6761,676
Diluted EPS excluding extraordinary itemsvalue per share0.42-0.080.710.01
Dividends per sharevalue per share0.370.370.370.37
Diluted normalized EPSvalue per share0.400.430.660.38